Otrivine Study
100+
Downloads
Jedes Alter
info
Über diese App
Welcome to the Otrivine Study:
The Otrivine app is a proprietary platform of ObvioHealth being used to manage a trial to study and evaluate the over-time effects of Otrivine on quality-of-life factors and cold symptoms among individuals experiencing nasal congestion associated with common cold until symptoms resolve or following up to 7 days of treatment, whichever comes first.
The Otrivine app removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.
The result? Robust data collection, increased compliance, faster time to completion, and average cost savings of ~50% vs. traditional on-site trials.
Subject Journey
A subject who is identified as eligible for this study during pre-screening will be invited to download the Otrivine App via e-mail.
Upon download, the participants create an account and are contacted by a study team member to complete the Informed Consent process. A series of screens explain the parameters of the study, including:
o Privacy Policy
o Data Gathering & Usage
o Study Tasks & Surveys
o Time Commitment
o Option to Withdraw
Subjects will connect with a member of the study team to ask questions and obtain a comprehensive understanding of the study prior to signing the informed consent form.
Intervention Period: Daily Tasks
Subjects will contribute data to the study by completing questionnaires and data uploads over a baseline period and an 8-day active trial period. Subjects can interact with the study team via secure chat as needed.
The Otrivine app is a proprietary platform of ObvioHealth being used to manage a trial to study and evaluate the over-time effects of Otrivine on quality-of-life factors and cold symptoms among individuals experiencing nasal congestion associated with common cold until symptoms resolve or following up to 7 days of treatment, whichever comes first.
The Otrivine app removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.
The result? Robust data collection, increased compliance, faster time to completion, and average cost savings of ~50% vs. traditional on-site trials.
Subject Journey
A subject who is identified as eligible for this study during pre-screening will be invited to download the Otrivine App via e-mail.
Upon download, the participants create an account and are contacted by a study team member to complete the Informed Consent process. A series of screens explain the parameters of the study, including:
o Privacy Policy
o Data Gathering & Usage
o Study Tasks & Surveys
o Time Commitment
o Option to Withdraw
Subjects will connect with a member of the study team to ask questions and obtain a comprehensive understanding of the study prior to signing the informed consent form.
Intervention Period: Daily Tasks
Subjects will contribute data to the study by completing questionnaires and data uploads over a baseline period and an 8-day active trial period. Subjects can interact with the study team via secure chat as needed.
Aktualisiert am
Was die Sicherheit angeht, solltest du als Erstes verstehen, wie Entwickler deine Daten erheben und weitergeben. Die Datenschutz- und Sicherheitspraktiken können je nach deiner Verwendung, deiner Region und deinem Alter variieren. Diese Informationen wurden vom Entwickler zur Verfügung gestellt und können jederzeit von ihm geändert werden.
Diese App kann die folgenden Datentypen an Dritte weitergeben
Personenbezogene Daten
Keine Daten erhoben
Daten werden bei der Übertragung verschlüsselt
Neuerungen
- Bug fixes
- UI and other enhancements
- UI and other enhancements
Support für diese App
phone
Telefonnummer
+16465990743
Informationen zum Entwickler
Obvio Health Usa, Inc.
obv-it@obviohealth.com
545 W 25th St Fl 20
New York, NY 10001
United States
+1 202-985-1618
